drugset / Trial / NCT00181896
Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is an 8-week open label study of bupropion SR in the treatment of youth with bipolar depression with adequate mood stabilization. All youth will be closely monitored for treatment emergent manic activation and drug-drug interactions with ongoing antimanic agents. The main objective of this study is to assess the safety and effectiveness of bupropion SR in the treatment of bipolar depression in children and adolescents.
Timeline
- Start
- 2005-01
- Primary completion
- 2007-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | — | — |